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Introduction: Intestinal zygomycosis is a rare infection by the fungi zygomycetes that have little intrinsic pathogenicity 
in normal hosts and mainly affects immune compromised patients. Mucor indicus is a rare, emerging cause of intestinal 
zygomycosis with only 8 reported cases in English literature since 1986.  
Presentation of Case: We reported an unusual case of toxic megacolon, fungal diverticulitis with perforation and liver 
abscesses caused by Mucor indicus in a patient with chronic myelogenous leukemia (CML), B-lymphoid blast crisis and 
pancytopenia. The patient was treated with total colectomy and aggressive systemic anti-fungal regimens consisting of 
amphotericin, caspofungin and posaconazole. However, his fungal abscess in the liver persisted after colectomy, which was 
confirmed by liver biopsy at four months after total colectomy. His CML and B-lymphoid blast crisis was successfully 
treated with hyper-CVAD plus dasatinib and had been in complete remission. The patient was alive and continued to have 
stable fungal infection in the liver based on CT scan at 32 months after total colectomy, for which he has been on 
posaconazole monotherapy. 
Conclusions: Mucor indicus may cause a rare invasive zygomycosis that tends to involve gastrointestinal tract and to 
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Introduction 
Zygomycosis is a fungal infection that can occur 
either in patients with no predisposing conditions 
immune compromised patients with hematologic 
malignancies, transplantation receiving 
immunosuppressive therapy, children with 
malnutrition, and patients with ketoacidotic 
diabetes, renal or heart failure.  Based on the 
common isolates, zygomycosis represents 
infections by the class zygomycetes, which 
the genera of Absidia, Mucor, Rhizomucor, 
Rhizopus, Cunninghamella, and others [1]. Mucor 
indicus is a rare, emerging cause of zygomycosis 
with only 8 cases previously reported in the 
literature. Interestingly, five such patients with 
Mucor indicus presented with 
pain or acute gastric bleeding, and the primary site 
of infection was found to be in the stomach, cecum, 
appendix or liver. To our knowledge, toxic 
megacolon and acute diverticulitis caused by 
Mucor indicus has not been reported. Here we 
reported a case of toxic megacolon and acute 
diverticulitis with perforation caused by Mucor 
indicus in a 60 year-old male, who had chronic 
myelogenous leukemia (CML), B-lymphoid blast 
crisis and severe pancytopenia. 
Presentation of the Case  
A 60-year-old male rancher, who initially 
with fatigue, weight loss and splenomegaly, was 
diagnosed with chronic myelogenous leukemia 
(CML) with philadelphia chromosome (Ph+) and 
BCR-ABL translocation [t(9:22)] in January of 
2008. He received induction chemotherapy with 
good response to nilotinib (400 mg daily) 
and remained asymptomatic. He had persistent 
grade 2 thrombocytopenia (platelet count: 
62,000/μl) and was slightly neutropenic one year 
after chemotherapy. His CML progressed to an 
accelerated blast phase (12% blast in bone marrow) 
and further into B-lymphoid blast crisis (62% 
in bone marrow), for which he was treated with 
hyper-CVAD 
(cyclophosphamide, vincristine, doxorubicin, and 
dexamethasone) and nilotinib treatment for nine 
months.  
During the blast crisis, the patient had one 
episode of fever and chills with accompanying 
abdominal pain. He was treated with unknown 
antimicrobials for presumed diverticulitis and his 
symptom resolved subsequently. Two weeks after 
initial antibiotics treatment, he had a repeated 
episode of fever and chill with an elevated liver 
functional test (ALT 218 IU/L, AST 163 IU/L, 
total bilirubin 10.7 mg/dL, alkaline phosphatase 
294 IU/L), neutropenia (white blood cell count: 
4900/μl with 142/μl neutrophils), anemia, and 
thrombocytopenia (platelet count 49,000/μl) that 
required a platelets transfusion. He was admitted 
to our hospital and was found to have E. coli 
bacteremia. His symptoms resolved after being 
treated with linezolid, tigecycline, tobramycin, 
voriconazole, and valacyclovir. He was discharged 
afebrile and asymptomatic and continued on 
antibiotics.  Within one week after discharge, the 
patient was readmitted to the hospital with 
worsening abdominal pain, recurrent fever, 
diarrhea, and dysuria. Computed tomography (CT) 
of the abdomen and pelvis showed diffuse bowel 
thickening of sigmoid colon with pelvic abscess, 
suggestive of acute diverticulitis with perforation 
of the sigmoid colon. The perforation was 
confined within the pelvis and there was no free 
air in the peritoneal cavity. The abscess was 
located between the sigmoid colon and urinary 
bladder, which accounts for the bladder spasms 
and dysuria. The CT scan also showed possible 
microabscesses in the liver and spleen. Cultures 
were obtained by percutaneous fine needle 
aspiration from abdomen, which revealed 
polymicrobial infection with fungal hyphae 
identified. The patient was persistently febrile and 
became more distended with diffuse tenderness of 
abdomen.  An emergency exploratory laparotomy 
was performed. Segmental sigmoid colon 
resection and subsequent total colectomy with 
surgical debridement were performed.  
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Figure 1 A. Gross photo of formalin fixed extended 
right hemicolectomy shows the toxic megacolon and 
transmural necrosis involving the cecum and proximal 
ascending colon with many hemorrhagic ulcers. B. 
Representative cross sections of the perforated fungal 
















Figure 2 Representative micrographs show transmural 
necrosis with hemorrhage (A & B). Numerous fungal 
hyphae present in the wall of colon involved by toxic 
megacolon (C). D and E, representative micrographs 
show numerous irregularly shaped, broad non-septate 
hyphae with the right angle branching (D, insert) in the 
colonic wall and invading the blood vessels. Fungal 
culture and identification confirmed infection by Mucor 
incidus. F. Periodic acid-Schiff (PAS) stain for fungus 
show the fungal hyphae in the needle core biopsy of 
liver abscess 4 months after the total colectomy. 
Original magnifications: 40x for A and B; 100x for D 














Figure 3 Representative Computed tomography (CT) 
scan image shows multiple liver abscesses at four 
months after surgery. 
 
Gross examination showed toxic megacolon 
involving the cecum and proximal ascending colon 
with many shallow, hemorrhagic ulcers in the 
distal ascending and transverse colon (Figure 1A) 
and severe acute diverticulitis with perforation in 
the sigmoid colon (Figure 1B). Microscopic 
examination reveals numerous fungal hyphae 
invading the colonic wall and blood vessels with 
hemorrhage in the segment of toxic megacolon, 
hemorrhagic ulcer beds, and the area of acute 
diverticulitis. Invasive fungal hyphae involved the 
full thickness of colonic wall and pericolonic 
adipose tissue at the perforation site of the sigmoid 
colon and the segment of toxic megacolon. The 
fungal hyphae were broad, non-septated with a 
typical right-angle branching (Figure 2). Fungal 
culture from the debridement tissue and 
identification studies at the University of Texas 
San Antonio Health Science Center confirmed 
mucor species, Mucor indicus. Tissue culture also 
identified candida albicans mixed with multiple 
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gram-negative and gram positive bacteria, which 
is consistent with perforation. Postoperatively, the 
patient was doing well with anti-fungal therapy 
and hyper-CVAD therapy for the lymphoid blast 
phase of CML. Four months after surgery, CT scan 
revealed multiple liver lesions which increase in 
size during the follow-up (Figure 3). Needle core 
biopsies of the liver lesion showed liver abscess 
with fungal hyphae morphologically consistent 
with Mucor indicus as seen in the toxic megacolon. 
The patient received extended combination 
antifungal therapy of amphotericin, caspofungin 
and posaconazole for 21 months after total 
colectomy. He has now been on monotherapy with 
posaconazole for the last 11 months. The patient 
continued to have stable disease in the liver based 
the CT scan. His CML and B-lymphoid blast crisis 
was successfully treated with hyper-CVAD plus 
dasatinib and is now in complete remission. At the 
last follow-up, the patient’s blood count was the 
following: hemoglobin 10.5 grams/dL; white 
blood cell count of 4100/µL with 53.4% of 
neutrophils, 27.3% of lymphocytes and 0.2% of 
immature ganulocytes; platelet of   58000/uL. 
BCR-ABL quantitative PCR show a BCR-ABL to 
ABL transcript ratio of <0.01. The bone marrow 
biopsy showed normocellular bone marrow with 
30% cellularity, mild dyserythropoiesis and 
megakaryocytic hypoplasia and no morphologic 
evidence of CML. The patient is alive at 32 
months after the total colectomy.   
Discussion 
Intestinal zygomycosis is an extremely rare 
invasive fungal infection mainly seen in patients 
with hematological malignancies, particularly in 
patients with therapy-induced neutropenia.  It is 
the third most common cause of fungal infection 
after candidiasis and aspergillosis [2, 3]. The 
diagnosis of zygomycosis is rarely suspected and 
antemortem diagnosis is made in only 23–50% of 
cases [4]. Early medical and surgical intervention 
is critical to prevent fatality. Our patient had CML 
with lymphoid blast phase and pancytopenia. He 
presented with acute abdomen due to perforated 
diverticulitis and toxic megacolon secondary to 
invasive Mucor indicus infection.  
It is believed that severe neutropenia poses the 
major risk for fungal infection when the absolute 
white blood cells counts of less than 1000/μl for 
one week or longer in immunocompromised 
patients [5]. Once infection is established, 
neutrophils play a pivotal role in fighting fungal 
infections in the normal host. In patients with 
neutropenia, the mortality rate from all reported 
cases of gastrointestinal zygomycosis is 85% [6].  
In 40% of the reported cases of gastrointestinal 
zygomycosis, the infection was disseminated to 
involve other organ systems and has a mortality 
rate close to 90% [7].  However, some patients 
may be cured by prompt surgical excision and 
effective anti-fungal treatment [1, 8]. Our patient 
was successful treated with total colectomy and 
antifungal treatment. Interestingly, he was found to 
have persistent disseminated infection of mucor 
indicus in the liver and spleen even after four 
months of anti-fungal therapy. To our knowledge, 
this is a first case of successfully treated intestinal 
mucomycosis in an immunosuppressed patient 
infected with mucor indicus, who had a 
complication of megacolon and disseminated 
fungal abscesses in both the liver and spleen. He is 
alive 32 months after colectomy with stable 
disease in the liver at the last follow-up. The 
remission of his CML, adequate WBC and 
antifugal treatment seems to contribute to the 
long-term suppression of the hepatic zygomycosis 
in our patient. 
Among the reported patients with 
gastrointestinal zygomycosis, stomach is the most 
frequent site of involvement (60% of the cases), 
followed by colon (30% of the cases) and small 
intestine (30% of the cases) [4] [9] [10]. Unlike 
rhinocerebral zygomycosis, the sign and 
symptoms of gastrointestinal zygomycosis are 
obscured in many cases by the underlying disease. 
Gastrointestinal zygomycosis, especially in 
colorectum, also tends to disseminate to liver 
 Zhao Q et al. American Journal of Clinical Cancer Research 2013, 1:45-50 
 Ivy Union Publishing | http: //www.ivyunion.org October 19, 2013 | Volume 1 | Issue 1
  
Page 5 of 6 
through portal system with abscess formation [11] 
[12]. A high clinical suspicion is required for 
timely diagnosis. Our patient has a previous 
diagnosis of diverticulitis, which was initially 
successfully treated with broad-spectrum 
antibacterials. His granulocytopenia and the 
prolonged treatment with broad-spectrum 
antibiotics may contribute to the infection of 
Mucor indicus, which has been thought to be 
acquired through direct ingestion of the pathogen 
[13]. The ubiquitous air or food-borne fungal 
spores may germinate in previous enterocolonic 
ulcers.   
Eight cases of human infection of Mucor 
indicus have been previous reported [6, 11, 13, 14], 
giving a total of nine cases including the present 
case. Five of these patients had predisposing 
conditions, including two patients with 
T-lymphoblastic leukemia or CML in 
B-lymphoblastic crisis and neutropenia, one with 
bone marrow transplant receiving prednisone for 
graft versus host disease, one with acute head 
injury and one patient with left ventricular assist 
device (LVAD). The remaining four patients had 
no known predisposing conditions. There were 
five male and four female patients with age 
ranging from 6 months to 82 years. Interestingly 
only two of these nine patients died of the 
infection, including one patient with both 
appendiceal and liver involvement and one patient 
with LVAD and involvement of heart and aorta. 
However, gastrointestinal zygomysosis caused by 
other species carries a fatality rate of 85% [6]. 
The diagnosis of gastrointestinal zygomycosis 
needs invasive procedure, biopsy and fungal 
culture. Endoscopy examination may show a black 
ulcer with deep red edges [14]. Biopsies from the 
edge of the ulcer are most likely to reveal fungi. 
The hyphae of zygomycosis are visible by routine 
hematoxylin-and-eosin (H & E) stain, Special 
stains such as periodic-acid-schiff (PAS) stain and 
the Gomori-methenamine silver (GMS) stain and 
fungal culture help to confirm the diagnosis. 
Amphotericin B remains the drug of choice, in 
conjunction with surgical resection.  
Conclusions 
Mucor indicus may cause a rare invasive 
zygomycosis that tends to involve gastrointestinal 
tract and to disseminate to liver through portal 
vein.  High suspicion in patients with neutropenia, 
proper tissue or blood culture in conjunction with 
radiographic studies, prompt surgical resection and 
systemic antifungal therapy are essential in cure 
and management. The mortality of this fungal 
infection may be better than those caused by other 
species in general. The remission of CML, 
adequate WBC and antifugal treatment seems to 
contribute to the long-term survival and 
suppression of hepatic zygomycosis in our patient. 
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